
ZBISF
Healthcare · Drug Manufacturers - Specialty & Generic · $122.6M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 14, 2021 | Time not confirmed | — | 0.01 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | 0.01 | — |
| Nov 12, 2020 | Time not confirmed | — | -0.02 | — |
| Sep 30, 2020 | Time not confirmed | — | -0.02 | — |
| Jun 30, 2020 | Time not confirmed | — | -0.03 | — |
| Mar 31, 2020 | Time not confirmed | — | -0.02 | — |
| Dec 31, 2019 | Time not confirmed | — | -0.21 | — |
| Sep 30, 2019 | Time not confirmed | -0.03 | -0.02 | +28.3% |
| Jun 30, 2019 | Time not confirmed | -0.04 | -0.07 | -76.0% |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.02 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.12 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | -0.01 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.02 | — |
Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-üp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in…
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.01 | — |